🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Contributor sign in
Latest
Clinical Trials in Turkey / NCT07520734
Recruiting Observational

Clinical Outcomes After Laser Hemorrhoidoplasty

NCT07520734 · tracked via the Priya Life Science Turkey tracker
Phase
Observational
Started
2026-06-01
Last updated
2026-07-09

Condition(s) studied

Hemorrhoidal DiseaseInternal Hemorrhoids

Investigational drug(s) / intervention(s)

Laser Hemorrhoidoplasty

Laser Hemorrhoidoplasty: Laser-based minimally invasive treatment of internal hemorrhoidal disease performed as part of routine clinical care.

Study summary

This single-center prospective observational study aims to evaluate clinical outcomes, postoperative pain scores, complications, and patient satisfaction in adults undergoing laser hemorrhoidoplasty for symptomatic internal hemorrhoidal disease. Additional objectives are to assess the relationship between hemorrhoid stage, dominant presenting symptoms, operative technical details, and postoperative outcomes. No study-specific intervention beyond routine clinical care and follow-up will be performed.

Eligibility

Sex
ALL
Min age
18 Years
Max age
—
Healthy volunteers
No
Inclusion Criteria: * Age 18 years or older * Symptomatic internal hemorrhoidal disease * Scheduled to undergo laser hemorrhoidoplasty * Willingness to participate and provision of informed consent Exclusion Criteria: * Grade IV hemorrhoidal disease * Acute thrombosed hemorrhoids * Additional anorectal pathology such as anal fissure, fistula, or perianal abscess * History of inflammatory bowel disease or colorectal malignancy * Previous major anal surgery'

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
Sanliurfa Education and Research Hospital Sanliurfa Şanlıurfa Recruiting

More Sanliurfa Education and Research Hospital trials in Turkey

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07520734 on ClinicalTrials.gov ↗ ← All trials in Turkey